U.S. Patent Issuance
On December 5, 2023, the United States Patent and Trademark Office allowed U.S. Patent 11,833,124 titled Compositions and Methods for Modulating HEXIM1 Expression that names Dr. Bin Su, a professor in the Department of Chemistry and a member of the Center for Gene Regulation in Health and Disease (GRHD), and Monica Montano, a professor in the Department of Pharmacology at the Case Western Reserve University School of Medicine.
The patented technology provides a solution to a failed Phase II clinical trial investigating Hexamethylene bis-acetamide (HMBA) as a potent anti-cancer drug due to its high toxicity. The patented invention modulates HEXIM1 to reduce the HBNA high toxicity. |
|
CTIA Wireless Foundation Launches Catalyst Competition
The CTIA Wireless Foundation launched its fifth annual Catalyst Competition. This year, more than $200,000 will go to emerging social entrepreneurs developing mobile-first solutions to enhance our lives and address challenges in American communities.
Ideal candidates are ambitious early-stage social entrepreneurs like this: https://youtu.be/-eRxzN2BK38
Up to six applicants will receive unrestricted grants, with a first-place award of $100,000. The top three winners will also receive a professionally produced video and opportunities to participate in speaking engagements and events for wireless industry leaders, elected officials, and policymakers. |